Subjects
This prospective, randomized, controlled study included 41 patients
diagnosed with De Quervain tenosynovitis, which had been ongoing for
more than 4 weeks, and who were admitted to
………………………………………between
May 2019 and March 2020. The patients were diagnosed clinically using
the Finkelstein test, in which the patient flexes the thumb and wraps
the fingers over thumb, then the physician stabilizes the forearm and
ulnarly deviates the wrist. The presence of pain over the abductor
pollicis longus and extensor pollicis brevis tendons is accepted as
positive test result. Patients were excluded from the study if they had
chronic widespread or local musculoskeletal pain due to rheumatological
diseases (i.e., fibromyalgia, rheumatoid arthritis), neurological
diseases (i.e., multiple sclerosis, cervical discopathy or plexopathy),
trauma or surgery to the related region (wrist, elbow or hand), or were
aged <18 years or >65 years. From the total 41
patients initially enrolled, 2 did not wish to participate in the study,
2 did not complete the treatment sessions and 1 patient did not attend
the evaluations at 1 month and 1 year after the end of the therapy.
Final evaluation was made of a total of 36 patients (NT group:18;
control group:18). Approval for the study was granted by the Ethics
Committee of
………………………………………
Clinical Trials Registration was approved (NCT04384536). Informed
consent was obtained from all the study participants.